Feiby L Nassan1, Jorge E Chavarro2, Candice Y Johnson3, James M Boiano3, Carissa M Rocheleau3, Janet W Rich-Edwards4, Christina C Lawson3. 1. Department of Environmental Health, Harvard T. H. Chan School of Public Health, Boston, MA; Department of Nutrition, Harvard T. H. Chan School of Public Health, Boston, MA. Electronic address: fen769@mail.harvard.edu. 2. Department of Nutrition, Harvard T. H. Chan School of Public Health, Boston, MA; Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, MA; Channing Division of Network Medicine, Harvard Medical School and Brigham and Women's Hospital, Boston, MA. 3. National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Cincinnati, OH. 4. Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, MA; Channing Division of Network Medicine, Harvard Medical School and Brigham and Women's Hospital, Boston, MA; Connors Center for Women's Health and Gender Biology and Division of Women's Health, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.
Abstract
PURPOSE: To examine the association betweenantineoplastic drug (AD) handling and risk of miscarriage. METHODS: Nurses' Health Study-3 participants self-reported AD administration and engineering controls (ECs) and personal protective equipment (PPE) use at baseline. We estimated the hazard ratio (HR) of miscarriage in relation to baseline AD handling using multivariable Cox proportional regression. RESULTS: Overall, 2440 nurses reported 3327 pregnancies, with 550 (17%) ended in miscarriages. Twelve percent of nurses self-reported currently handling AD and 28% previously handling AD. Compared with nurses who never handled AD, nurses who handled AD at baseline had an adjusted HR of miscarriage of 1.26 (95% confidence interval [CI], 0.97-1.64). This association was stronger after 12-weeks gestation (HR=2.39 [95% CI, 1.13-5.07]). Nurses who did not always use gloves had HR of 1.51 (95% CI, 0.91-2.51) compared with 1.19 (95% CI, 0.89-1.60) for those always using gloves; nurses who did not always use gowns had HR of 1.32 (95% CI, 0.95-1.83) compared with 1.19 (95% CI, 0.81-1.75) for nurses always using gowns. CONCLUSIONS: We observed a suggestive association between AD handling and miscarriage, particularly among nurses who did not consistently use PPE and EC with stronger associations for second trimester losses.
PURPOSE: To examine the association betweenantineoplastic drug (AD) handling and risk of miscarriage. METHODS: Nurses' Health Study-3 participants self-reported AD administration and engineering controls (ECs) and personal protective equipment (PPE) use at baseline. We estimated the hazard ratio (HR) of miscarriage in relation to baseline AD handling using multivariable Cox proportional regression. RESULTS: Overall, 2440 nurses reported 3327 pregnancies, with 550 (17%) ended in miscarriages. Twelve percent of nurses self-reported currently handling AD and 28% previously handling AD. Compared with nurses who never handled AD, nurses who handled AD at baseline had an adjusted HR of miscarriage of 1.26 (95% confidence interval [CI], 0.97-1.64). This association was stronger after 12-weeks gestation (HR=2.39 [95% CI, 1.13-5.07]). Nurses who did not always use gloves had HR of 1.51 (95% CI, 0.91-2.51) compared with 1.19 (95% CI, 0.89-1.60) for those always using gloves; nurses who did not always use gowns had HR of 1.32 (95% CI, 0.95-1.83) compared with 1.19 (95% CI, 0.81-1.75) for nurses always using gowns. CONCLUSIONS: We observed a suggestive association between AD handling and miscarriage, particularly among nurses who did not consistently use PPE and EC with stronger associations for second trimester losses.
Authors: Wouter Fransman; Nel Roeleveld; Susan Peelen; Wim de Kort; Hans Kromhout; Dick Heederik Journal: Epidemiology Date: 2007-01 Impact factor: 4.822
Authors: David M DeJoy; Todd D Smith; Henok Woldu; Mari-Amanda Dyal; Andrea L Steege; James M Boiano Journal: J Occup Environ Hyg Date: 2017-07 Impact factor: 2.155
Authors: Brady P Selig; James R Furr; Ryan W Huey; Colin Moran; Vinod N Alluri; Gregory R Medders; Christina D Mumm; H Gene Hallford; John J Mulvihill Journal: Birth Defects Res A Clin Mol Teratol Date: 2012-07-31
Authors: Christina C Lawson; Candice Y Johnson; Feiby L Nassan; Thomas H Connor; James M Boiano; Carissa M Rocheleau; Jorge E Chavarro; Janet W Rich-Edwards Journal: Am J Nurs Date: 2019-01 Impact factor: 2.220